|
Q2 FY2026
As of Jun 30, 2026
|
Q4 FY2026
As of Dec 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
|
|---|---|---|---|---|---|---|
| Assets | ||||||
| Current assets | ||||||
| Cash | ||||||
| Note receivable | ||||||
| Prepaid expenses | ||||||
| Short-term prepaid insurance | ||||||
| Total current assets | ||||||
| Long-term prepaid insurance | ||||||
| Cash held in the Trust Account | ||||||
| Total Assets | ||||||
| Liabilities and Shareholders’ Deficit | ||||||
| Current liabilities | ||||||
| Accounts payable and accrued expenses | ||||||
| Accrued offering costs | ||||||
| Total current liabilities | ||||||
| Deferred legal fees | ||||||
| Deferred underwriting fee payable | ||||||
| Total Liabilities | ||||||
| Class A ordinary shares subject to possible redemption, 19,000,000 shares at redemption value of $10.53 and $10.37 per share at June 30, 2026 and December 31, 2025, respectively | ||||||
| Common Class A | ||||||
| Total class A ordinary shares subject to possible redemption, 19,000,000 shares at redemption value of $10.53 and $10.37 per share at June 30, 2026 and December 31, 2025, respectively | ||||||
| Shareholders’ Deficit | ||||||
| Ordinary shares, value | ||||||
| Common Class A | ||||||
| Common Class B | ||||||
| Accumulated deficit | ||||||
| Total Shareholders’ Deficit | ||||||
| Total Liabilities and Shareholders’ Deficit |
Loading...
